- Report
- July 2026
- 190 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 187 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 183 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 182 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 193 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 182 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 182 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 197 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 180 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 191 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 182 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- January 2026
- 184 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- January 2026
- 188 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- August 2025
- 184 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- June 2026
- 191 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- February 2026
- 250 Pages
Global
From €4084EUR$4,490USD£3,491GBP
- Report
- July 2026
- 377 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 182 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 192 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP
- Report
- July 2026
- 199 Pages
Global
From €3224EUR$3,545USD£2,756GBP
€3583EUR$3,939USD£3,062GBP

The Antimicrobial Resistance Surveillance (ARS) market is a subset of the Diagnostics industry, focused on the detection and monitoring of antimicrobial resistance. ARS involves the collection and analysis of data on the prevalence of antimicrobial resistance in a population, as well as the identification of the genetic elements responsible for the resistance. This data is used to inform public health policy and to guide the development of new treatments and strategies to combat antimicrobial resistance. ARS is a rapidly growing market, driven by the increasing prevalence of antimicrobial resistance and the need for better surveillance and monitoring.
Companies in the ARS market include bioMérieux, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more